Provides an overview of gender differences in heart failure based on population-based studies, highlighting the selection bias in clinical trials.
Answers are grounded in this paper and cite their sources.
Urges inclusive HF trial enrollment to mitigate gender bias; leaves open sex-specific recommendations pending higher-quality data.
andomised clinical trials of drug treatment for chronic heart failure are the basis of many physicians ’ beliefs about heart failure. Due to the selection bias of such studies—which preferentially recruit relatively young white men with coronary artery disease—relatively little attention has focused on gender differences in heart failure. This article provides an overview of such gender differences, based on population-based studies in North America and Europe. PREVALENCE It is difficult to make comparisons between prevalence studies (and across time) due to differences in the case definitions employed.1 There is no ‘‘gold standard’ ’ for heart failure, and most recent studies rely heavily on echocardio-graphy to demonstrate underlying cardiac abnormalities in patients with symptoms that might be caused by heart
No takes yet. Share an insight, caveat, or question.
P. K. Mehta (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: